NIFTY® — The World's Leading Non-Invasive Fetal Trisomy Test. Over 13,700,000 tested worldwide.
Introducing

The NIFTY® test, made personal.

NIFTY® (Non-Invasive Fetal TrisomY test) is a safe, simple non-invasive prenatal screen (NIPT) that examines fetal DNA from a single maternal blood draw — from as early as week 10. Using geneticlab BGI's latest DNBSEQ-G99 sequencing platform, the only one in the UAE at geneticlab, it delivers over 99% accuracy for Down, Edwards, and Patau syndromes.

Advantages

Five reasons clinicians and parents choose NIFTY®.

Reliable

Up to 99% sensitivity and specificity, validated by clinical studies worldwide.

Safe

Non-invasive with no risk of miscarriage — only maternal blood is required.

Simple

Just 6–10 mL of venous blood collected from the pregnant woman by a clinician.

Comprehensive

Screens 22 trisomies, 4 sex chromosome abnormalities, 84 microdeletion/duplication syndromes, and fetal sex.

Fast

Reports issued in 5–7 working days to help physicians make rapid clinical decisions.

Technology

Genomics-grade sequencing, clinically validated.

An Emirati laboratory scientist operating a DNA sequencer
  • Blood sampling is safe, convenient, and entirely non-invasive.
  • High-throughput sequencing covering 95+18 tests and additional findings.
  • High-quality QC monitoring of cell-free fetal DNA concentration.
  • Clinically validated for twin pregnancies.

International certification

  • International patented analysis — PCT/CN2011/001070
  • 50+ peer-reviewed international clinical papers
  • Reported by in UAE
What we screen

Comprehensive screening, in a single test.

22

Chromosomal trisomies

Including T21, T18, T13

4

Sex chromosome abnormalities

XO, XXX, XXY, XYY

84

Microdeletion / duplication syndromes

Across all chromosomes

1

Fetal sex determination

On request

Service process

From blood draw to clinical report — in three quiet steps.

Blood collection01

Blood collection

Only 6–10 mL of intravenous blood is collected by a medical professional — no risk to mother or fetus.

Local sequencing, in UAE02

Local sequencing, in UAE

Samples are analyzed at our state-of-the-art lab in Sahara Healthcare City, UAE. is one of very few select facilities in the UAE capable of in-house NIPT sequencing, and the only one using BGI's high-throughput DNBSEQ sequencing of cell-free fetal DNA.

Clinical report03

Clinical report

Your report is available in 5–7 working days, reviewed and issued by in UAE.

A trusted collaboration

GeneticLabNIFTY®BGI
About geneticlab

World-class genomic diagnostics, delivered by .

Based in the UAE and partnered with BGI, geneticlab brings the world's most advanced sequencing technology to expecting families and clinicians across the region.

Advanced DNA Sequencing

DNBSEQ-G99 — the only platform of its kind in the UAE — for precise, high-throughput genomic analysis.

Clinical-Grade Workflows

Validated end-to-end protocols from sample collection to reporting, audited for consistency and safety.

Class I UAE Medical Lab

Licensed by the UAE Ministry of Health and operating under the highest medical laboratory standards.

Globally Validated

Backed by 50+ international clinical studies and over 13.7 million tests performed worldwide.

geneticlab laboratory interior with advanced sequencing equipment
TRUSTED CLINICAL PARTNER
CAP AccreditedMOH Licensed
Enquire

The health of your child is the most important conversation you'll have.

Share a few details and a specialist will reach out to guide you through the NIFTY® test, timing, and what to expect.

Your information is handled confidentially and used only to respond to your enquiry.